Search by Drug Name or NDC
NDC 00338-1719-40 Magnesium Sulfate 4 g/50mL Details
Magnesium Sulfate 4 g/50mL
Magnesium Sulfate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
| NDC | 00338-1719 |
|---|---|
| Product ID | 0338-1719_b5a8b04e-abe3-41fd-adb7-7f968118bf52 |
| Associated GPIs | 79400010402065 |
| GCN Sequence Number | 063497 |
| GCN Sequence Number Description | magnesium sulfate in water PIGGYBACK 4 G/50 ML INTRAVEN |
| HIC3 | C1H |
| HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
| GCN | 99223 |
| HICL Sequence Number | 039652 |
| HICL Sequence Number Description | MAGNESIUM SULFATE IN STERILE WATER |
| Brand/Generic | Generic |
| Proprietary Name | Magnesium Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Magnesium Sulfate Heptahydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | g/50mL |
| Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211966 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1719-40 (00338171940)
| NDC Package Code | 0338-1719-40 |
|---|---|
| Billing NDC | 00338171940 |
| Package | 40 BAG in 1 CARTON (0338-1719-40) / 50 mL in 1 BAG |
| Marketing Start Date | 2020-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |